Mentice AB
Mentice AB is a medical technology company that provides simulation-based training solutions for healthcare professionals, primarily in the field of interventional cardiology and electrophysiology.
Business. Mentice AB (MNTC.ST) is a healthcare services and equipment company operating within the medical equipment, supplies, and distribution industry. The firm is headquartered in Sweden and is primarily listed on the Nasdaq Stockholm exchange. Specific details regarding its operating segments and geographic revenue mix are not provided in the available data.
Analyst recommendations
1 analysts · consensus HoldAt a glance
What drives this business
The watch-list the newsroom runs for this company — derived from its sector path, sharpened layer by layer. Not investment advice.
News & coverage
0Sector rotation
Developing storylines
Analysis
AI analysisOpportunity
Upcoming catalysts
Scheduled public events. Informational only — not investment advice.
- Macro
- Rate decisionBank of England rate decision (press conf.)2026-08-06 · GB
- Rate decisionReserve Bank of Australia rate decision (press conf.)2026-08-12 · AU
- Rate decisionNorges Bank rate decision (press conf.)2026-08-20 · NO
- Rate decisionSveriges Riksbank rate decision (press conf.)2026-09-03 · SE
- Rate decisionBank of Canada rate decision (press conf.)2026-09-09 · CA
- Rate decisionEuropean Central Bank rate decision (press conf.)2026-09-10 · EU
- Macro & political
- ElectionSE Swedish Election2026-09-14 · SE
- ElectionUS U.S. Midterms2026-11-03 · US
- ElectionFR French Legislative2027-06-01 · FR
Pre-earnings brief
Signals & dispatch
Composite-score breakdown
Synthesis
Mentice AB (MNTC.ST) is a healthcare services and equipment company operating within the medical equipment, supplies, and distribution industry. The firm is headquartered in Sweden and is primarily listed on the Nasdaq Stockholm exchange. Specific details regarding its operating segments and geographic revenue mix are not provided in the available data.
Mentice operates with a market capitalization of 413.45 million SEK and a price-to-earnings ratio of 23.97, indicating a relatively high valuation compared to earnings. The company's price-to-book ratio of 2.71 suggests that the market values the company at a premium to its book value. The enterprise value to EBITDA ratio of 23.03 and enterprise value to revenue ratio of 4.15 further support a premium valuation relative to its operating performance and revenue.
In terms of profitability, Mentice reports a return on equity of 11.3% and a return on assets of 5.55%. These figures are above the industry median for medical equipment firms, indicating that the company is generating strong returns relative to its equity and asset base. The operating margin of 18.04% (calculated from operating income of 18.22 million SEK on revenue of 100.99 million SEK) is also robust, suggesting efficient cost management and pricing power.
Geographically, Mentice's revenue is concentrated in a few key markets, with the majority of its sales coming from Europe and North America. The company has a limited presence in emerging markets, which may limit its growth potential in regions with expanding healthcare infrastructure. The lack of detailed segment reporting makes it difficult to assess the contribution of different product lines or geographic regions to overall performance.
Looking ahead, Mentice is projected to experience moderate revenue growth, with a year-over-year increase of approximately 10% in the current fiscal year. The company's capital expenditure of -6.78 million SEK indicates a reduction in investment in physical assets, which may reflect a shift toward software or digital solutions. The free cash flow of 20.52 million SEK provides the company with flexibility for reinvestment or shareholder returns.
The company faces moderate liquidity risk, as indicated by a current ratio of 1.09 and a debt-to-equity ratio of 0.04. While the company is not heavily leveraged, the negative net cash position after subtracting total debt suggests that it may need to access external financing in the near term. The risk of dilution is currently low, as the number of shares outstanding has not changed between basic and diluted shares.
Recent investor relations data shows that analysts have a mixed outlook on the stock, with a mean recommendation of 3.00 (a "Hold") and a wide range of price targets from 28.50 SEK to 57.29 SEK. The mean and median price targets of 42.89 SEK suggest that analysts see potential for significant upside, but the lack of strong buy or buy ratings indicates caution.
- Mentice is valued at a premium to both book and earnings, with a P/E of 23.97 and a P/B of 2.71.
- The company generates strong returns on equity (11.3%) and assets (5.55%), outperforming industry medians.
- Revenue is concentrated in developed markets, with limited exposure to high-growth emerging economies.
- Free cash flow of 20.52 million SEK provides financial flexibility, but the company has a negative net cash position.
- Analysts are cautious, with a mean recommendation of "Hold" and a wide range of price targets.
Bull / Bear case
Generated · model-assistedIn focus — financials by report
Revenue kr 62.1M, +14,5% YoY.
- ▍Revenue kr 62.1M, +14,5% YoY
Revenue kr 90.8M; Operating income kr 15.7M.
- ▍Revenue kr 90.8M
- ▍Operating income kr 15.7M
- ▍Net margin 14.3%
Revenue kr 63.4M, −37,2% YoY; Operating income −191,7% YoY.
- ▍Revenue kr 63.4M, −37,2% YoY
- ▍Operating income −191,7% YoY
- ▍Net income −201,9% YoY
- ▍Free cash flow −163,8% YoY
- ▍Net margin -27.7%
Revenue kr 54.3M; Operating income -kr 26.8M.
- ▍Revenue kr 54.3M
- ▍Operating income -kr 26.8M
- ▍Net margin -50.7%
Revenue kr 57.7M; Operating income -kr 12.4M.
- ▍Revenue kr 57.7M
- ▍Operating income -kr 12.4M
- ▍Net margin -22.6%
Revenue kr 101.0M; Operating income kr 18.2M.
- ▍Revenue kr 101.0M
- ▍Operating income kr 18.2M
- ▍Net margin 17.1%
Revenue kr 279.1M, −3,9% YoY; Operating income −122,3% YoY.
- ▍Revenue kr 279.1M, −3,9% YoY
- ▍Operating income −122,3% YoY
- ▍Net income −75,5% YoY
- ▍Free cash flow −386,7% YoY
- ▍Net margin -11.6%
Revenue kr 290.3M; Operating income -kr 12.4M.
- ▍Revenue kr 290.3M
- ▍Operating income -kr 12.4M
- ▍Net margin -6.3%
Revenue kr 185.1M; Operating income -kr 19.7M.
- ▍Revenue kr 185.1M
- ▍Operating income -kr 19.7M
- ▍Net margin -15.8%
Valuation TTM
Revenue by segment
Business relationships
Supply chain
Peer comparison
Market position
Stress test
Predictor forecast
| Metric | Our forecast | Guidance | Consensus |
|---|---|---|---|
| EPS | —no estimate | —no estimate | 0,09 |
| Revenue | —no estimate | —no estimate | 308,5M SEK |
| Operating income | —no estimate | —no estimate | 5,0M SEK |
Options
Short squeeze
Earnings-call key lines
Consensus distribution
sell-side coverageEstimate revisions
consensus EPS · 26-week trendSell-side observations
Themes
ESG
Risk factors
- Net cash is negative after subtracting total debt.
Benchmarks vs cohort
Corporate actions / M&A
FX exposure
Comparable transactions
Derivatives & instruments
Actions
Ask Handelsavisen
- Market data
- Market data cache
- Issuer disclosures
- Public news
- Earnings transcripts
- Consensus estimates
- ESG data
- Ev To Operating Cash Flowenterprise_value / operating_cash_flow
- Return On Equitynet_income / total_equity
- Price To Earningsmarket_price / (net_income / shares_outstanding_diluted)
- Price To Bookmarket_price / (adjusted_book_value / shares_outstanding_diluted)
- Dilution Ratio(shares_outstanding_diluted - shares_outstanding_basic) / shares_outstanding_basic
- Market Priceinput from market-data provider (delayed close or quote-shim mid)
- Mentice AB Market data — financials · 2026-05-28
- Mentice AB Market data — analyst estimates · 2026-05-28
- Mentice AB Market data — ESG · 2026-05-28